ReP USP - Resultado da busca

Artigo de periodico
Population genomic evidence of structured and connected Plasmodium vivax populations under host selection in Latin America (2024)
Kattenberg, Johanna Helena ; Monsieurs, Pieter ; Julie De Meyer ; Meulenaere, Katlijn De ; Sauve, Erin ; Oliveira, Thaís Crippa de ; Gamboa, Dionicia ; Rosanas-Urgell, Anna ; Ferreira, Marcelo Urbano
Source: Ecology and Evolution. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM, PLASMODIUM FALCIPARUM, DIVERSIDADE GENÉTICA, GENOMAS, MALÁRIA, GEOGRAFIA DA POPULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KATTENBERG, Johanna Helena et al. Population genomic evidence of structured and connected Plasmodium vivax populations under host selection in Latin America. Ecology and Evolution, v. 14, n. 3, p. 17 , 2024Tradução . . Disponível em: https://doi.org/10.1002/ece3.11103. Acesso em: 15 jun. 2024.
APA
Kattenberg, J. H., Monsieurs, P., Julie De Meyer,, Meulenaere, K. D., Sauve, E., Oliveira, T. C. de, et al. (2024). Population genomic evidence of structured and connected Plasmodium vivax populations under host selection in Latin America. Ecology and Evolution, 14( 3), 17 . doi:https://doi.org/10.1002/ece3.11103
NLM
Kattenberg JH, Monsieurs P, Julie De Meyer, Meulenaere KD, Sauve E, Oliveira TC de, Gamboa D, Rosanas-Urgell A, Ferreira MU. Population genomic evidence of structured and connected Plasmodium vivax populations under host selection in Latin America [Internet]. Ecology and Evolution. 2024 ; 14( 3): 17 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1002/ece3.11103
Vancouver
Kattenberg JH, Monsieurs P, Julie De Meyer, Meulenaere KD, Sauve E, Oliveira TC de, Gamboa D, Rosanas-Urgell A, Ferreira MU. Population genomic evidence of structured and connected Plasmodium vivax populations under host selection in Latin America [Internet]. Ecology and Evolution. 2024 ; 14( 3): 17 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1002/ece3.11103
Artigo de periodico
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children (2024)
Bastard, Paul ; Adrian, Gervais ; Taniguchi, Maki ; Saare, Liisa ; Särekannu, Karita ; Voyer, Tom Le ; Philippot, Quentin ; Rosain, Jérémie ; Bizien, Lucy ; Asano, Takaki Asano ; Garcia-Prat, Marina ; Parra-Martínez, Alba ; Migaud, Mélanie ; Tsumura, Miyuki ; Conti, Francesca ; Belot, Alexandre ; Rivière, Jacques G. ; Morio, Tomohiro ; Tanaka, Junko ; Javouhey, Etienne ; Haerynck, Filomeen ; Duvlis, Sotirija ; Ozcelik, Tayfun ; Keles, Sevgi ; Redondo, Yacine Tandjaoui-Lambiotte ; Escoda, Simon ; Husain, Maya ; Pan-Hammarström, Qiang ; Hammarström, Lennart ; Ahlijah, Gloria ; Haidar, Anthony Abi ; Soudee, Camile ; Arsegue, Vincent; Abolhassani, Hassan ; Sahanic, Sabina ; Tancevsk, Ivan ; Nukui, Yoko ; Hayakawa, Seiichi ; Chrousos, George P. ; Michos, Athanasios ; Tatsi, Elizabeth-Barbara ; Filippatos, Filippos ; Seuma, Agusti Rodriguez-Palmero ; Garcia, Jésus Troya ; Tipu, Imran ; Meyts, Isabelle ; Roussel, Lucie ; Ostrowski, Sisse Rye ; Schidlowski, Laire ; Prando, Carolina ; Cheikh, Nathalie ; Bousfiha, Ahmed Aziz ; Bakkouri, Jalila El ; Peterson, Pärt ; Pujol, Aurora ; Lévy, Romain ; Quartier, Pierre ; Vinh, Donalod C. ; Boisson, Bertrand ; Béziat, Vivien ; Zhang, Shen-Ying ; Borghesi, Alessandro ; Pession, Andrea ; Andreakos, Evangelos ; Marr, Nico ; Mentis, Alexios-Fotios A. ; Mogensen, Trine Hyrup ; Rodríıguez-Gallego, Carlos ; Soler-Palacín, Pere ; Colobran, Roger ; Tillmann, Vallo ; Neven, Bénédicte ; Trouillet-Assant, Sophie ; Brodin, Peter ; Abel, Laurent ; Jouanguy, Emmanuelle ; Zhang, Qian ; Martinón-Torres, Federico ; Ellacuriaga, Antonio Sallas ; Gómez-Carballa, Alberto ; Gonzalez-Granado, Luis Ignacio ; Kisan, Kai ; Okada, Satoshi ; Puel, Anne ; Cobat, Aurélie ; Casanova, Jean-Laurent ; Condino Neto, Antonio
Source: The Journal of Experimental Medicine. Unidade: ICB
Subjects: IMUNOLOGIA, AUTOANTICORPOS, COVID-19, PNEUMONIA, PNEUMOPATIAS, INTERFERON TIPO I, INTERFERONS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. The Journal of Experimental Medicine, v. 221, n. 2, p. 45 , 2024Tradução . . Disponível em: https://doi.org/10.1084/jem.20231353. Acesso em: 15 jun. 2024.
APA
Bastard, P., Adrian, G., Taniguchi, M., Saare, L., Särekannu, K., Voyer, T. L., et al. (2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. The Journal of Experimental Medicine, 221( 2), 45 . doi:10.1084/jem.20231353
NLM
Bastard P, Adrian G, Taniguchi M, Saare L, Särekannu K, Voyer TL, Philippot Q, Rosain J, Bizien L, Asano TA, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Redondo YT-L, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Haidar AA, Soudee C, Arsegue V, Abolhassani H, Sahanic S, Tancevsk I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi E-B, Filippatos F, Seuma AR-P, Garcia JT, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Cheikh N, Bousfiha AA, Bakkouri JE, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang S-Y, Borghesi A, Pession A, Andreakos E, Marr N, Mentis A-FA, Mogensen TH, Rodríıguez-Gallego C, Soler-Palacín P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Ellacuriaga AS, Gómez-Carballa A, Gonzalez-Granado LI, Kisan K, Okada S, Puel A, Cobat A, Casanova J-L, Condino Neto A. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children [Internet]. The Journal of Experimental Medicine. 2024 ; 221( 2): 45 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1084/jem.20231353
Vancouver
Bastard P, Adrian G, Taniguchi M, Saare L, Särekannu K, Voyer TL, Philippot Q, Rosain J, Bizien L, Asano TA, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Redondo YT-L, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Haidar AA, Soudee C, Arsegue V, Abolhassani H, Sahanic S, Tancevsk I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi E-B, Filippatos F, Seuma AR-P, Garcia JT, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Cheikh N, Bousfiha AA, Bakkouri JE, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang S-Y, Borghesi A, Pession A, Andreakos E, Marr N, Mentis A-FA, Mogensen TH, Rodríıguez-Gallego C, Soler-Palacín P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Ellacuriaga AS, Gómez-Carballa A, Gonzalez-Granado LI, Kisan K, Okada S, Puel A, Cobat A, Casanova J-L, Condino Neto A. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children [Internet]. The Journal of Experimental Medicine. 2024 ; 221( 2): 45 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1084/jem.20231353
Artigo de periodico
Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2 (2023)
Perrotti, Edvige ; L'Episcopia, Mariangela ; Menegon, Michela ; Soares, Irene da Silva ; Rosas-Aguirre, Angel ; Speybroeck, Niko; LLanos Cuentas, Alejandro ; Menard, Didier ; Ferreira, Marcelo Urbano ; Severini, Carlo
Source: Parasites & Vectors. Unidades: FCF, ICB
Subjects: PLASMODIUM, VARIAÇÃO GENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERROTTI, Edvige et al. Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2. Parasites & Vectors, v. 16, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13071-023-05851-9. Acesso em: 15 jun. 2024.
APA
Perrotti, E., L'Episcopia, M., Menegon, M., Soares, I. da S., Rosas-Aguirre, A., Speybroeck, N., et al. (2023). Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2. Parasites & Vectors, 16, 1-11. doi:10.1186/s13071-023-05851-9
NLM
Perrotti E, L'Episcopia M, Menegon M, Soares I da S, Rosas-Aguirre A, Speybroeck N, LLanos Cuentas A, Menard D, Ferreira MU, Severini C. Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2 [Internet]. Parasites & Vectors. 2023 ; 16 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1186/s13071-023-05851-9
Vancouver
Perrotti E, L'Episcopia M, Menegon M, Soares I da S, Rosas-Aguirre A, Speybroeck N, LLanos Cuentas A, Menard D, Ferreira MU, Severini C. Reduced polymorphism of Plasmodium vivax early transcribed membrane protein (PvETRAMP) 11.2 [Internet]. Parasites & Vectors. 2023 ; 16 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1186/s13071-023-05851-9
Artigo de periodico
Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys (2022)
Ferreira, Marcelo Urbano ; Corder, Rodrigo Malavazi ; Johansen, Igor Cavallini ; Kattenberg, Johanna H.; Moreno, Marta; Aguirre, Angel Rosas ; Andrade, Simone Ladeia ; Conn, Jan E. ; Cuentas, Alejandro Llanos ; Gamboa, Dionicia ; Urgell, Anna Rosanas ; Vinetz, Joseph M.
Source: Lancet Regional Health. Americas. Unidade: ICB
Subjects: PARASITOLOGIA, INFECÇÕES POR PROTOZOÁRIOS, PLASMODIUM, MALÁRIA, ESTUDOS TRANSVERSAIS, REAÇÃO EM CADEIA POR POLIMERASE, MICROSCOPIA ELETRÔNICA ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Marcelo Urbano et al. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Regional Health. Americas, v. 9, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2021.100169. Acesso em: 15 jun. 2024.
APA
Ferreira, M. U., Corder, R. M., Johansen, I. C., Kattenberg, J. H., Moreno, M., Aguirre, A. R., et al. (2022). Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Regional Health. Americas, 9, 1-11. doi:10.1016/j.lana.2021.100169
NLM
Ferreira MU, Corder RM, Johansen IC, Kattenberg JH, Moreno M, Aguirre AR, Andrade SL, Conn JE, Cuentas AL, Gamboa D, Urgell AR, Vinetz JM. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys [Internet]. Lancet Regional Health. Americas. 2022 ; 9 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.lana.2021.100169
Vancouver
Ferreira MU, Corder RM, Johansen IC, Kattenberg JH, Moreno M, Aguirre AR, Andrade SL, Conn JE, Cuentas AL, Gamboa D, Urgell AR, Vinetz JM. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys [Internet]. Lancet Regional Health. Americas. 2022 ; 9 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.lana.2021.100169
Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 15 jun. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico-carta/editorial
Primary immunodeficiencies: a decade of progress and a promising future (2021)
Meyts, Isabelle ; Bousfiha, Aziz; Duff, Carla ; Singh, Surjit; Lau, Yu Lung ; Condino Neto, Antonio ; Bezrodnik, Liliana ; Ali, Adli ; Adeli, Mehdi ; Drabwell, José
Source: Frontiers in Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, COVID-19, IMUNOGENÉTICA, INFECÇÕES POR CORONAVIRUS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEYTS, Isabelle et al. Primary immunodeficiencies: a decade of progress and a promising future. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2020.625753. Acesso em: 15 jun. 2024. , 2021
APA
Meyts, I., Bousfiha, A., Duff, C., Singh, S., Lau, Y. L., Condino Neto, A., et al. (2021). Primary immunodeficiencies: a decade of progress and a promising future. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.3389/fimmu.2020.625753
NLM
Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino Neto A, Bezrodnik L, Ali A, Adeli M, Drabwell J. Primary immunodeficiencies: a decade of progress and a promising future [Internet]. Frontiers in Immunology. 2021 ; 11 5 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.3389/fimmu.2020.625753
Vancouver
Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino Neto A, Bezrodnik L, Ali A, Adeli M, Drabwell J. Primary immunodeficiencies: a decade of progress and a promising future [Internet]. Frontiers in Immunology. 2021 ; 11 5 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.3389/fimmu.2020.625753
Artigo de periodico
Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus (2021)
Steiner, Annemarie; Reygaerts, Thomas ; Pontillo, Alessandra ; Ceccherini, Isabella ; Moecking, Jonas ; Moghaddas, Fiona ; Davidson, Sophia ; Caroli, Francesco ; Grossi, Alice ; Castro, Fabio Fernandes Morato ; Kalil Filho, Jorge Elias ; Gohr, Florian N. ; Schmidt, Florian I.; Bartok, Eva ; Zillinger, Thomas ; Hartmann, Gunther ; Geyer, Matthias ; Gattorno, Marco ; Mendonça, Leonardo Oliveira ; Masters, Seth L.
Source: Journal of Clinical Immunology. Unidades: ICB, FM
Subjects: IMUNOLOGIA, COLITE ULCERATIVA, DOENÇAS DO SISTEMA DIGESTÓRIO, INFLAMAÇÃO, COMPLEXOS MULTIENZIMÁTICOS, MACRÓFAGOS, ENTEROPATIAS, SEQUÊNCIA DO DNA, MUTAÇÃO GENÉTICA, EXONS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEINER, Annemarie et al. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus. Journal of Clinical Immunology, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10875-021-01175-4. Acesso em: 15 jun. 2024.
APA
Steiner, A., Reygaerts, T., Pontillo, A., Ceccherini, I., Moecking, J., Moghaddas, F., et al. (2021). Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus. Journal of Clinical Immunology, 1-11. doi:10.1007/s10875-021-01175-4
NLM
Steiner A, Reygaerts T, Pontillo A, Ceccherini I, Moecking J, Moghaddas F, Davidson S, Caroli F, Grossi A, Castro FFM, Kalil Filho JE, Gohr FN, Schmidt FI, Bartok E, Zillinger T, Hartmann G, Geyer M, Gattorno M, Mendonça LO, Masters SL. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus [Internet]. Journal of Clinical Immunology. 2021 ; 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s10875-021-01175-4
Vancouver
Steiner A, Reygaerts T, Pontillo A, Ceccherini I, Moecking J, Moghaddas F, Davidson S, Caroli F, Grossi A, Castro FFM, Kalil Filho JE, Gohr FN, Schmidt FI, Bartok E, Zillinger T, Hartmann G, Geyer M, Gattorno M, Mendonça LO, Masters SL. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus [Internet]. Journal of Clinical Immunology. 2021 ; 1-11.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s10875-021-01175-4
Artigo de periodico
In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling (2021)
Romualdo, Guilherme Ribeiro; Leroy, Kaat ; Costa, Cícero Júlio Silva ; Prata, Gabriel Bacil ; Vanderborght, Bart; Silva, Tereza Cristina da; Barbisan, Luis Fernando ; Andraus, Wellington ; Devisscher, Lindsey ; Câmara, Niels Olsen Saraiva ; Vinken, Mathieu ; Cogliati, Bruno
Source: Cancers. Unidades: FM, ICB, FMVZ
Subjects: CARCINOMA HEPATOCELULAR, MODELOS ANIMAIS DE DOENÇAS, MODELOS FISIOLÓGICOS, HEPATOPATIAS, CARCINOGÊNESE ANIMAL, MUATAÇÃO GÊNICA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMUALDO, Guilherme Ribeiro et al. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, v. 13, n. 21, p. 1-57, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13215583. Acesso em: 15 jun. 2024.
APA
Romualdo, G. R., Leroy, K., Costa, C. J. S., Prata, G. B., Vanderborght, B., Silva, T. C. da, et al. (2021). In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, 13( 21), 1-57. doi:10.3390/cancers13215583
NLM
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3390/cancers13215583
Vancouver
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3390/cancers13215583
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 15 jun. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elżbieta ; Drolet, Beth A. ; Zhang, Qian ; O’Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 15 jun. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O’Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O’Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico-carta/editorial
Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elżbieta ; Drolet, Beth A. ; Zhang, Qian ; O’Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Su, Helen C. ; Casanova, Jean-Laurent ; Spaan, András N. ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41590-021-01096-9. Acesso em: 15 jun. 2024. , 2021
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41590-021-01096-9
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O’Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O’Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Artigo de periodico
2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling (2021)
Ferreira, Rafael Augusto Alves; Rezende Junior, Celso de ; Martinez, Pablo David Grigol ; Koovits, Paul John ; Soares, Bruna Miranda ; Ferreira, Leonardo Luiz Gomes ; Duarte, Simone Michelan ; Chelucci, Rafael Consolin; Andricopulo, Adriano Defini ; Galuppo, Mariana Kolos ; Uliana, Silvia Reni Bortolin ; Matheeussen, An ; Caljon, Guy ; Maes, Louis ; Campbell, Simon; Kratz, Jadel M. ; Mowbray, Charles E. ; Dias, Luiz Carlos
Source: PLOS Neglected Tropical Diseases. Unidades: IFSC, ICB
Subjects: ANTIPARASITÁRIOS, LEISHMANIA INFANTUM, PLANEJAMENTO DE FÁRMACOS, PARASITOLOGIA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, TOXICIDADE EM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael Augusto Alves et al. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling. PLOS Neglected Tropical Diseases, v. 15, n. 2, p. e0009196-1-e0009196-20, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0009196. Acesso em: 15 jun. 2024.
APA
Ferreira, R. A. A., Rezende Junior, C. de, Martinez, P. D. G., Koovits, P. J., Soares, B. M., Ferreira, L. L. G., et al. (2021). 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling. PLOS Neglected Tropical Diseases, 15( 2), e0009196-1-e0009196-20. doi:10.1371/journal.pntd.0009196
NLM
Ferreira RAA, Rezende Junior C de, Martinez PDG, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Galuppo MK, Uliana SRB, Matheeussen A, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 15( 2): e0009196-1-e0009196-20.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1371/journal.pntd.0009196
Vancouver
Ferreira RAA, Rezende Junior C de, Martinez PDG, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Galuppo MK, Uliana SRB, Matheeussen A, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. 2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling [Internet]. PLOS Neglected Tropical Diseases. 2021 ; 15( 2): e0009196-1-e0009196-20.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1371/journal.pntd.0009196
Artigo de periodico
Genome analysis of endotrypanum and porcisia spp., closest phylogenetic relatives of Leishmania, highlights the role of amastins in shaping pathogenicity (2021)
Albanaz, Amanda T. S.; Gerasimov, Evgeny S. ; Shaw, Jeffrey Jon ; Sádlová, Jovana ; Lukeš, Julius ; Volf, Petr ; Opperdoes, Fred R. ; Kostygov, Alexei Y. ; Butenko, Anzhelika ; Yurchenko, Vyacheslav
Source: Genes. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIA, DANO AO DNA, GENOMAS, PROTEÍNAS RECOMBINANTES, MASTIGOPHORA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBANAZ, Amanda T. S. et al. Genome analysis of endotrypanum and porcisia spp., closest phylogenetic relatives of Leishmania, highlights the role of amastins in shaping pathogenicity. Genes, v. 12, n. 3, p. 1-20, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12030444. Acesso em: 15 jun. 2024.
APA
Albanaz, A. T. S., Gerasimov, E. S., Shaw, J. J., Sádlová, J., Lukeš, J., Volf, P., et al. (2021). Genome analysis of endotrypanum and porcisia spp., closest phylogenetic relatives of Leishmania, highlights the role of amastins in shaping pathogenicity. Genes, 12( 3), 1-20. doi:10.3390/genes12030444
NLM
Albanaz ATS, Gerasimov ES, Shaw JJ, Sádlová J, Lukeš J, Volf P, Opperdoes FR, Kostygov AY, Butenko A, Yurchenko V. Genome analysis of endotrypanum and porcisia spp., closest phylogenetic relatives of Leishmania, highlights the role of amastins in shaping pathogenicity [Internet]. Genes. 2021 ; 12( 3): 1-20.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3390/genes12030444
Vancouver
Albanaz ATS, Gerasimov ES, Shaw JJ, Sádlová J, Lukeš J, Volf P, Opperdoes FR, Kostygov AY, Butenko A, Yurchenko V. Genome analysis of endotrypanum and porcisia spp., closest phylogenetic relatives of Leishmania, highlights the role of amastins in shaping pathogenicity [Internet]. Genes. 2021 ; 12( 3): 1-20.[citado 2024 jun. 15 ] Available from: https://doi.org/10.3390/genes12030444
Artigo de periodico
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) (2021)
Roos, Dirk; Leeuwen, Karin van; Hsu, Amy P.; Priel, Debra Long ; Begtrup, Amber ; Brandon, Rhonda; Stasia, Marie José ; Bakri, Faris Ghalib ; Köker, Nezihe ; Köker, Mustafa Yavuz ; Madkaika, Manisha; Boer, Martin de ; Morato, Maria Bravo Garcia ; Shephard, Juan Luis Valdivieso; Roesler, Joachim ; Kanegane, Hirokazu ; Kawai, Toshinao ; Matteo, Gigliola Di ; Shahrooei, Mohammad ; Bustamante, Jacinta ; Rawat, Amit ; Vignesh, Pandiarajan ; Mortaz, Esmaeil ; Fayezi, Abbas; Cagdas, Deniz ; Tezcan, Ilhan ; Kitcharoensakkul, Maleewan ; Dinauer, Mary C. ; Meyts, Isabelle; Wolach, Baruch; Condino Neto, Antonio ; Zerbe, Christa S. ; Holland, Steven M.; Malech, Harry L. ; Gallin, John I.; Kuhns, Douglas B.
Source: Blood Cells, Molecules and Diseases. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, SUPERÓXIDO DISMUTASE, ATIVAÇÃO ENZIMÁTICA, IMUNOGENÉTICA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOS, Dirk et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, v. 90, p. 1-36, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2021.102587. Acesso em: 15 jun. 2024.
APA
Roos, D., Leeuwen, K. van, Hsu, A. P., Priel, D. L., Begtrup, A., Brandon, R., et al. (2021). Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, 90, 1-36. doi:10.1016/j.bcmd.2021.102587
NLM
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Vancouver
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Artigo de periodico
Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells (2020)
Santos, Daiane Fernanda dos; Pilger, Denise Regina Bairros de; Vandermeulen, Charlotte; Khouri, Ricardo; Mantoani, Susimaire Pedersoli; Nunes, Paulo Sergio Gonçalves; Andrade, Peterson de; Carvalho, Ivone ; Casseb, Jorge Simão do Rosário ; Twizere, Jean-Claude; Willems, Luc; Freitas Junior, Lucio Holanda Gondim de; Haddad, Simone Kashima
Source: Bioorganic & Medicinal Chemistry. Unidades: FCFRP, FM, ICB, FMRP
Subjects: APOPTOSE, PROLIFERAÇÃO CELULAR, VÍRUS, RETROVIRIDAE, NEOPLASIAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Daiane Fernanda dos et al. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells. Bioorganic & Medicinal Chemistry, v. 28, n. 22, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115746. Acesso em: 15 jun. 2024.
APA
Santos, D. F. dos, Pilger, D. R. B. de, Vandermeulen, C., Khouri, R., Mantoani, S. P., Nunes, P. S. G., et al. (2020). Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells. Bioorganic & Medicinal Chemistry, 28( 22), 1-9. doi:10.1016/j.bmc.2020.115746
NLM
Santos DF dos, Pilger DRB de, Vandermeulen C, Khouri R, Mantoani SP, Nunes PSG, Andrade P de, Carvalho I, Casseb JS do R, Twizere J-C, Willems L, Freitas Junior LHG de, Haddad SK. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 22): 1-9.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.bmc.2020.115746
Vancouver
Santos DF dos, Pilger DRB de, Vandermeulen C, Khouri R, Mantoani SP, Nunes PSG, Andrade P de, Carvalho I, Casseb JS do R, Twizere J-C, Willems L, Freitas Junior LHG de, Haddad SK. Non-cytotoxic 1,2,3-triazole tethered fused heterocyclic ring derivatives display Tax protein inhibition and impair HTLV-1 infected cells [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 22): 1-9.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.bmc.2020.115746
Artigo de periodico
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network (2020)
Hossain, Mohammad Sharif ; Commons, Robert J. ; Douglas, Nicholas M. ; Thriemer, Kamala ; Alemayehu, Bereket H. ; Amaratunga, Chanaki; Anvikar, Anupkumar R. ; Ashley, Elizabeth A. ; Asih, Puji B. S. ; Carrara, Verena I. ; Lon, Chanthap ; D’Alessandro, Umberto ; Davis, Timothy M. E. ; Dondorp, Arjen M. ; Edstein, Michael D. ; Fairhurst, Rick M. ; Ferreira, Marcelo Urbano ; Hwang, Jimee ; Janssens, Bart; Karunajeewa, Harin ; Kiechel, Jean R. ; Andrade, Simone Ladeia ; Laman, Moses ; Mayxay, Mayfong ; McGready, Rose ; Moore, Brioni R. ; Mueller, Ivo ; Newton, Paul N. ; Nhien, Nguyen T. Thuy ; Noedl, Harald; Nosten, Francois ; Phyo, Aung P. ; Poespoprodjo, Jeanne R. ; Saunders, David L.; Smithuis, Frank ; Spring, Michele D. ; Stepniewska, Kasia ; Suon, Seila; Suputtamongkol, Yupin ; Syafruddin, Din ; Tran, Hien T.; Valecha, Neena ; Herp, Michel Van ; Vugt, Michele Van ; White, Nicholas J. ; Guerin, Philippe J. ; Simpson, Julie A. ; Price, Ric N.
Source: PLoS Medicine (print). Unidade: ICB
Subjects: PARASITOLOGIA, ANTIMALÁRICOS, MALÁRIA, PLASMODIUM FALCIPARUM, ESTUDOS RANDOMIZADOS, ESTUDOS DE COORTES, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOSSAIN, Mohammad Sharif et al. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS Medicine (print), v. 17, n. 11, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pmed.1003393. Acesso em: 15 jun. 2024.
APA
Hossain, M. S., Commons, R. J., Douglas, N. M., Thriemer, K., Alemayehu, B. H., Amaratunga, C., et al. (2020). The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS Medicine (print), 17( 11). doi:10.1371/journal.pmed.1003393
NLM
Hossain MS, Commons RJ, Douglas NM, Thriemer K, Alemayehu BH, Amaratunga C, Anvikar AR, Ashley EA, Asih PBS, Carrara VI, Lon C, D’Alessandro U, Davis TME, Dondorp AM, Edstein MD, Fairhurst RM, Ferreira MU, Hwang J, Janssens B, Karunajeewa H, Kiechel JR, Andrade SL, Laman M, Mayxay M, McGready R, Moore BR, Mueller I, Newton PN, Nhien NTT, Noedl H, Nosten F, Phyo AP, Poespoprodjo JR, Saunders DL, Smithuis F, Spring MD, Stepniewska K, Suon S, Suputtamongkol Y, Syafruddin D, Tran HT, Valecha N, Herp MV, Vugt MV, White NJ, Guerin PJ, Simpson JA, Price RN. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network [Internet]. PLoS Medicine (print). 2020 ; 17( 11):[citado 2024 jun. 15 ] Available from: https://doi.org/10.1371/journal.pmed.1003393
Vancouver
Hossain MS, Commons RJ, Douglas NM, Thriemer K, Alemayehu BH, Amaratunga C, Anvikar AR, Ashley EA, Asih PBS, Carrara VI, Lon C, D’Alessandro U, Davis TME, Dondorp AM, Edstein MD, Fairhurst RM, Ferreira MU, Hwang J, Janssens B, Karunajeewa H, Kiechel JR, Andrade SL, Laman M, Mayxay M, McGready R, Moore BR, Mueller I, Newton PN, Nhien NTT, Noedl H, Nosten F, Phyo AP, Poespoprodjo JR, Saunders DL, Smithuis F, Spring MD, Stepniewska K, Suon S, Suputtamongkol Y, Syafruddin D, Tran HT, Valecha N, Herp MV, Vugt MV, White NJ, Guerin PJ, Simpson JA, Price RN. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network [Internet]. PLoS Medicine (print). 2020 ; 17( 11):[citado 2024 jun. 15 ] Available from: https://doi.org/10.1371/journal.pmed.1003393
Artigo de periodico
Alterations in cellular force parameters and cell projections in Nasal polyps-derived fibroblasts (2019)
Amaral, Jônatas Bussador do; Bloise Junior, Antonio Carlos; França, Carolina Nunes; Novo, Claudina Perez; Santelli, Gláucia Maria Machado ; Alencar, Adriano Mesquita ; Pezato, Rogério
Source: Auris Nasus Larynx. Unidades: IF, ICB
Subjects: MECÂNICA ESTATÍSTICA, CITOFISIOLOGIA, FIBROBLASTOS, PÓLIPOS NASAIS, MICROSCOPIA, ESPECTROSCOPIA DE RESSONÂNCIA MAGNÉTICA NUCLEAR, FÍSICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Jônatas Bussador do et al. Alterations in cellular force parameters and cell projections in Nasal polyps-derived fibroblasts. Auris Nasus Larynx, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.anl.2019.06.007. Acesso em: 15 jun. 2024.
APA
Amaral, J. B. do, Bloise Junior, A. C., França, C. N., Novo, C. P., Santelli, G. M. M., Alencar, A. M., & Pezato, R. (2019). Alterations in cellular force parameters and cell projections in Nasal polyps-derived fibroblasts. Auris Nasus Larynx. doi:10.1016/j.anl.2019.06.007
NLM
Amaral JB do, Bloise Junior AC, França CN, Novo CP, Santelli GMM, Alencar AM, Pezato R. Alterations in cellular force parameters and cell projections in Nasal polyps-derived fibroblasts [Internet]. Auris Nasus Larynx. 2019 ;[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.anl.2019.06.007
Vancouver
Amaral JB do, Bloise Junior AC, França CN, Novo CP, Santelli GMM, Alencar AM, Pezato R. Alterations in cellular force parameters and cell projections in Nasal polyps-derived fibroblasts [Internet]. Auris Nasus Larynx. 2019 ;[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.anl.2019.06.007
Artigo de periodico
X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world (2019)
El-Sayed, Zeinab A. ; Abramova, Irina ; Aldave, Juan Carlos ; Al-Herz, Waleed ; Bezrodnik, Liliana ; Boukari, Rachida ; Bousfilha, Ahmed Aziz; Cancrini, Caterina ; Dbaibo, Ghassan ; Derfalvi, Beata; Dogu, Figen ; Edgar, J. Davi M.; Eley, Brian ; El-Owaidy, Rasha Hasan ; Espinosa-Padilla, Sara Elva; Galal, Nermeen ; Haerynck, Filomeen ; Hanna-Wakim, Rima ; Hossny, Elham ; Ikinciogullari, Aydan ; Kamal, Ebtihal; Kanegane, Hirokaku ; Kechout, Nadia ; Lau, Yu Lung ; Morio, Tomohiro; Moschese, Viviana ; Neves, João Farela ; Quederni, Monia; Paganelli, Roberto ; Paris, Kenneth ; Pignata, Claudia; Plebani, Alessandro ; Qamar, Farah Naz; Qureshi, Sonia ; Radhakrishnan, Nita ; Rezaei, Nima; Rosario, Nelson ; Routes, John ; Sanchez, Berta; Sediva, Anna ; Seppanen, Mikko Risto Juhana ; Serrano, Edith Gonzalez ; Shcherbina, Anna ; Singh, Surjit ; Siniah, Sangeetha; Spadaro, Guiseppe; Tang, Mimi ; Vinet, Ana Maria; Volokha, Alla ; Sullivan, Kathleen E. ; Condino Neto, Antonio
Source: World Allergy Organization Journal. Unidade: ICB
Subjects: FENÓTIPOS, AGAMAGLOBULINEMIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGLOBULINAS, GENÉTICA APLICADA, ALERGIA E IMUNOLOGIA, VACINAS, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EL-SAYED, Zeinab A. et al. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, v. 12, p. 9 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.waojou.2019.100018. Acesso em: 15 jun. 2024.
APA
El-Sayed, Z. A., Abramova, I., Aldave, J. C., Al-Herz, W., Bezrodnik, L., Boukari, R., et al. (2019). X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world. World Allergy Organization Journal, 12, 9 . doi:10.1016/j.waojou.2019.100018
NLM
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018
Vancouver
El-Sayed ZA, Abramova I, Aldave JC, Al-Herz W, Bezrodnik L, Boukari R, Bousfilha AA, Cancrini C, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, El-Owaidy RH, Espinosa-Padilla SE, Galal N, Haerynck F, Hanna-Wakim R, Hossny E, Ikinciogullari A, Kamal E, Kanegane H, Kechout N, Lau YL, Morio T, Moschese V, Neves JF, Quederni M, Paganelli R, Paris K, Pignata C, Plebani A, Qamar FN, Qureshi S, Radhakrishnan N, Rezaei N, Rosario N, Routes J, Sanchez B, Sediva A, Seppanen MRJ, Serrano EG, Shcherbina A, Singh S, Siniah S, Spadaro G, Tang M, Vinet AM, Volokha A, Sullivan KE, Condino Neto A. X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world [Internet]. World Allergy Organization Journal. 2019 ; 12 9 .[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/j.waojou.2019.100018
Artigo de periodico
The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes (2018)
Meyerovich, Kira; Ortis, Fernanda ; Cardozo, Alessandra Kupper
Source: Journal of Molecular Endocrinology. Unidade: ICB
Subjects: BIOLOGIA CELULAR, LINFÓCITOS B, DIABETES MELLITUS, CITOCINAS, INFLAMAÇÃO, PROTEÍNAS QUINASES, PROLIFERAÇÃO CELULAR, ILHOTAS DE LANGERHANS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEYEROVICH, Kira e ORTIS, Fernanda e CARDOZO, Alessandra Kupper. The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes. Journal of Molecular Endocrinology, v. 61, n. 2, p. F1–F6, 2018Tradução . . Disponível em: https://doi.org/10.1530/JME-16-0183. Acesso em: 15 jun. 2024.
APA
Meyerovich, K., Ortis, F., & Cardozo, A. K. (2018). The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes. Journal of Molecular Endocrinology, 61( 2), F1–F6. doi:10.1530/JME-16-0183
NLM
Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes [Internet]. Journal of Molecular Endocrinology. 2018 ; 61( 2): F1–F6.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1530/JME-16-0183
Vancouver
Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes [Internet]. Journal of Molecular Endocrinology. 2018 ; 61( 2): F1–F6.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1530/JME-16-0183
Artigo de periodico
Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition (2018)
Nardelli, Tarlliza Romanna; Vanzela, Emerielle C.; Benedicto, Keli C.; Brozzi, Flora; Fujita, André ; Cardozo, Alessandra Kupper ; Eizirik, Décio L. ; Boschero, Antonio C ; Ortis, Fernanda
Source: Journal of Molecular Endocrinology. Unidades: IME, ICB
Subjects: DIABETES MELLITUS, PROLACTINA, BIOINFORMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDELLI, Tarlliza Romanna et al. Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition. Journal of Molecular Endocrinology, v. 61, n. 1, p. 25-36, 2018Tradução . . Disponível em: https://doi.org/10.1530/JME-16-0257. Acesso em: 15 jun. 2024.
APA
Nardelli, T. R., Vanzela, E. C., Benedicto, K. C., Brozzi, F., Fujita, A., Cardozo, A. K., et al. (2018). Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition. Journal of Molecular Endocrinology, 61( 1), 25-36. doi:10.1530/JME-16-0257
NLM
Nardelli TR, Vanzela EC, Benedicto KC, Brozzi F, Fujita A, Cardozo AK, Eizirik DL, Boschero AC, Ortis F. Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition [Internet]. Journal of Molecular Endocrinology. 2018 ; 61( 1): 25-36.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1530/JME-16-0257
Vancouver
Nardelli TR, Vanzela EC, Benedicto KC, Brozzi F, Fujita A, Cardozo AK, Eizirik DL, Boschero AC, Ortis F. Prolactin protects against cytokine-induced beta-cell death by NFκB and JNK inhibition [Internet]. Journal of Molecular Endocrinology. 2018 ; 61( 1): 25-36.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1530/JME-16-0257

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration